However, the timeline for visible weight loss varies: Weeks 14: Appetite reduction begins, and patients may notice subtle changes in portion control
35 Teunisse, S., Bollen, A
Clinical trial data demonstrate that discontinuation of semaglutide leads to gradual weight regain in most patients, with studies showing approximately two-thirds of lost weight returning within one year of stopping treatment
However, the durability of these neuroprotective effects remains unclear, as the study did not evaluate whether benefits persisted after probiotic discontinuation
A series of three to six sessions produces the best result
For the research community, vendors like Simple Peptide fill an important gap between clinical trial availability and potential future commercial approval